Released on = August 2, 2006, 6:20 am

Press Release Author = Visiongain

Industry = Pharmaceuticals

Press Release Summary = The purpose of this visiongain report is to analyse the
extent to which online e-solutions will contribute to the pharmaceutical sector
during the period 2006-2011.

Press Release Body = San Francisco, CA and London, UK; 20 July 2006: The purpose of
this visiongain report is to analyse the extent to which online e-solutions will
contribute to the pharmaceutical sector during the period 2006-2011. Report author
Dr Gordon Low said, \"Pharmaceutical eMarketing to consumers and prescribing doctors
will continue to grow steadily. Online technologies will become increasingly
important as mass-media DTC advertising faces growing resistance from consumers and
regulators. Also, diminishing returns from medical sales forces will drive the
industry further towards eDetailing." Nevertheless, spending on other promotional
channels -especially traditional detailing - will overshadow investments in
pharmaceutical eMarketing from 2006-2011, visiongain predicts.

In this report, visiongain forecasts that spending on eMarketing/promotion by the
pharmaceutical industry will grow steadily from 2006-2011, reaching over $480m by
2011. There will also be an expansion of ePrescribing and online sales of
pharmaceuticals. The Internet is an ideal channel for transmitting both
brand-specific and educational campaigns, especially through interactive content.
The potential for improved efficiency and cost savings are great, both to industry
and other healthcare providers. There are also great opportunities for suppliers of
technology platforms for online healthcare.

ePharma: The Online Pharmaceutical Industry, 2006-2011 examines eMarketing,
ePrescribing and online drug sales critically through comprehensive primary and
secondary research. In addition to consultation with experts in eMarketing and
ePrescribing, this research involved a detailed study of policy documents,
industrial reports and relevant news. Importantly, Visiongain applied techniques
such as financial forecasting, SWOT analyses and qualitative projections. The result
is a comprehensive market-based report with detailed analysis and informed opinion.

It is therefore vital for pharmaceutical companies to invest in online marketing and
sales technologies now, to harness their great potential and to achieve pre-emptive
competitive advantages. The range of electronic solutions for pharmaceutical sales,
marketing and prescribing is vast, with both the Internet and mobile communications
showing significant promise.

ENDS

Notes for editors:
To receive your complimentary overview of this report please send an email to Sara
Peerun sara.peerun@visiongain.com, telephone Sara on +44 (0) 20 8767 6711 or visit
the media section on www.visiongainintelligence.com. Please include your full name,
title of publication, contact telephone number, email and details of where you saw
this release. Upon receipt of this information, an overview will be emailed to you.

Background:
Visiongain is one of the fastest growing and most innovative independent media
companies in Europe today. Based in London, UK, visiongain produce a host of
business-2-business conferences, newsletters, management reports and E-Zines
focusing on the Financial markets, the Pharmaceutical, Telecoms industries and the
Defence sector.


Web Site = http://www.visiongain.com

Contact Details = BSG House,
226-236 City Road
London EC1V 2QY
UK
Tel. 00442073366100